IGENICA BIOTHERAPEUTICS, INC — Form D/A
IGENICA BIOTHERAPEUTICS, INC of BURLINGAME, CA, a company, filed a Form D amendment with the SEC on 2011-09-28. The offering totals $24.1M, of which $16.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-09-28
- Form: D/A
- Accession: 0001453044-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $24.1M
- Amount sold: $16.1M
- Remaining: $8.0M
- Investors: 6
- Date of first sale: 2010-04-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-141481
Issuer
- Name: IGENICA BIOTHERAPEUTICS, INC
- CIK: 0001453044
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 863A MITTEN RD., BURLINGAME, CA, 94040
- Phone: (650) 231-4320
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Mike Rothe | Director | Burlingame, CA |
| Mike Rothe | Executive Officer | Burlingame, CA |
| CARL GORDON | Director | SAN DIEGO, CA |
| David Goeddel | Director | Agoura Hills, CA |
| David Goeddel | Executive Officer | Agoura Hills, CA |
| Mary Haak-Frendscho | Director | Hayward, CA |
| Mary Haak-Frendscho | Executive Officer | Hayward, CA |
| Mark A Goldsmith | Director | Redwood City, CA |
| John Celebi | Executive Officer | Cambrdge, MA |
| John Diekman | Director | Menlo Park, CA |
| Mark Goldsmith | Director | Burlingame, CA |
| Robert Schreiber | Director | Burlingame, CA |
| Gwen Fyfe | Director | Burlingame, CA |
| John A Celebi | Executive Officer | Burlingame, CA |
| Gwen A Fyfe | Director | Burlingame, CA |
| Guoqing Chen | Executive Officer | Burlingame, CA |
| Luis Bayol | Executive Officer | South San Francisco, CA |
Other filings by this issuer (11)
More